Securing funds is a by product of great processes, rich pipelines, and thorough due diligence. If you are curing cancer, we are here to help. ∞ pipeline of high-impact ideas relevant to your work & lab's capacity 💰 intelligence from analyzing more than $1.4B in funded cancer research 📝 wisdom of 8M published research papers in oncology at your fingertips Tailwind is an amplifier of oncologists potential to find groundbreaking cures to cancer, especially those at NCI designated centers & research institutions. We are now opening beta releases for such oncologists. Ask us how! #endcancer
Jori’s Post
More Relevant Posts
-
May is National Cancer Research Month. The AACR collaborated with more than 20 international organizations and institutions in 2023 to advance cancer research around the world. Learn more in the AACR Annual Impact Report: https://bit.ly/3Kmqt7L #NCRM24
To view or add a comment, sign in
-
-
Thanks to investments in research, lung cancer is seeing much better outcomes. It's why Annarita Egidi believes that research unlocks new possibilities - from early detection and more personalized care. May this long continue with more research. #BecauseofResearch #LCAM #lungcancer #research Young Lung Cancer Initiative
To view or add a comment, sign in
-
-
“We’re not just funding research; we’re building a global network and pushing the boundaries of what’s possible in cancer research.” - Mark Foundation CEO Ryan Schoenfeld Read Gevorg Tamamyan's interview with Schoenfeld in OncoDaily to learn how we’re accelerating discovery in the fight against cancer. https://lnkd.in/e33bd2NH #CancerResearch #ResearchFunding
To view or add a comment, sign in
-
-
#MRFResearchWednesday -- “Our research explores CD4+ T cells as a treatment option for melanoma, particularly for patients resistant to current immunotherapies. By defining factors that control how CD4+ T cells engage melanoma, we aim to identify novel pathways that may be therapeutically targeted,” says Korbinian Kropp, MD of Memorial Sloan Kettering Cancer Center. Learn more about Dr. Korbinian's recent research funded through our Career Development Award and its impact on the #melanoma patient community here -- https://lnkd.in/gHea3KcN
To view or add a comment, sign in
-
-
🧬 Keynote Speaker: Dr. James Kirkland at VSS 2024 🧬 Day two of the 9th Annual Vail Scientific Summit began with a powerful keynote by Dr. James Kirkland, MD, PhD, from Cedars-Sinai, Los Angeles. Dr. Kirkland delivered an insightful talk on Gerotherapeutics: Translation From Bench to Bedside. He highlighted his ambitious plan to spend the next five years fighting some of the deadliest forms of cancer. According to the National Cancer Institute (NCI), nearly 10 million cancer-related deaths occurred worldwide in 2022—a figure projected to rise to 15 million by 2040—underscoring the urgency of Dr. Kirkland’s research. #VSS2024 #VailScientificSummit2024 #ResearchMatters #FocusOnPatientCare #NovelTherapeutics #CancerResearch #Gerotherapeutics #MedicalInnovation #CedarsSinai #FutureOfMedicine
To view or add a comment, sign in
-
-
Chris Baldwin, PhD, MBA and Sofia Bazakou are attending the Health-RI Oncology Node Workshop today, where they will dive into important discussions around Common Data Models and Metadata Catalogues in cancer research. The workshop will be an interactive platform for building a standardized approach in oncology data integration, with a focus on tools like cBioPortal and how we can work together to streamline cancer research. Can't wait to be part of this exciting event! 🌈 If you're attending, be sure to connect with our Hyvers. #OncologyResearch #CommonDataModels #cBioPortal #Metadata #CancerResearch #HealthRI #DataIntegration #TheHyve #InnovationInCancer
To view or add a comment, sign in
-
-
Last week I attended this Innovation Series Seminar! I am really happy for what NUNO Prego Ramos has achieved! Also, this success story is an inspiration for biotech projects from Portugal! The quality of the content was huge, but I will highlight: 1) Aim for something bigger than ourselves; 2) Negative experiences give you lessons to learn; 3) Manage people with transparency. I would say that the key to success is take care of your relationships! #entrepreneurship #innovation #technologytransfer
💡 The first open session of the Innovation Speaker Series with guest speaker NUNO Prego Ramos is this Wednesday, 29 May - Join us! Our guest will share the journey of CellmAbs, from its early days starting with an initial technology from NOVA University to becoming a pioneering force in cancer therapy innovation 🙌 The Innovation Speaker Series was originally designed to introduce the Champalimaud Foundation’s Community on how to bring their research to the marketplace, but this session is open to all. 🎙️ NUNO Prego Ramos, Co-Founder and CEO of CellmAbs 📅 29 May 24 🕒 3pm 📍 Seminar Room, Champalimaud Foundation 🎟️ Free event, but RSVP is required: https://lnkd.in/daEYBGwS #InnovationSpeakerSeries #FreeEvent #BiotechInnovation Nina Patrick, PhD
To view or add a comment, sign in
-
-
Understanding the risk factors and biology of #ProstateCancer is key to improving treatment options. Unfortunately, there continues to be a lack of representation and inclusivity in cancer research. With our Phase 3 LIBERTAS study, one of the first transgender-inclusive study protocols in prostate cancer, we are breaking new ground on what cancer care looks like. This #ProstateCancerAwarenessMonth, learn more about our innovative approach to prostate cancer research: https://lnkd.in/e3ydmaFs #JNJOncology
To view or add a comment, sign in
-
As the fight against cancer continues to evolve, so does the National Foundation for Cancer Research—adapting to emerging scientific trends and transformative technologies and incorporating state-of-the-art methodologies into its grant programs. Learn more about how NFCR is preparing for the future of cancer research by visiting: https://lnkd.in/guP4TgbB #NFCR #MakeCuresPossible #Cancer #Research #Vision #Future #CancerResearch #Investinginthefuture #annualreport
To view or add a comment, sign in
-
-
📢The Science Report 2023 highlights how last year's research continues to drive progress in the fight against childhood cancers. International collaboration remains at the heart of our efforts, allowing us to generate valuable insights and impactful publications that are shaping future breakthroughs. 🎗️ The work we accomplished in 2023 is not simply a look back—it’s the foundation for ongoing innovation in cancer research. 👉 Discover how global partnerships and cutting-edge science are pushing boundaries in oncology. Read the full report now >>> https://ccri.at/reports/ #ScienceReport #CancerResearch #Collaboration #Oncology
To view or add a comment, sign in
-